Gel Stent Market Size, Share, Sales, Analysis, Forecast by Clinical Trials (Pre-clinical, Research, Clinical Phase I/II, Clinical Phase III, Clinical Phase I and Clinical Phase II), By End Use (Eye Clinics, Eye Research Institutes, and Hospitals), Industry Competition & Player Profiles, 2022 – 2032

In medical terms, a stent is a plastic or a metal tube that is used for penetrating into the patient’s lumen of an anatomic vessel or duct to keep the passageway open. A stent is a small tube that is expandable, and is used in the treatment of narrowed arteries. It is also placed in weak arteries to improve the blood flow and to prevent the arteries from bursting. Stenting is what the placement of a stent is called, and there are various different ways for the stents insertion. A variety of stents is used for different purposes, right from expandable biliary (procedure to open the obstructed bile duct), coronary, and vascular stents, to simple plastic stents that allow the flow of urine between the kidney and bladder. On the other hand, a gel stent is a type of hydrophilic tube, which consists of porcine gelatin that is cross-linked with glutaraldehyde. This type of stent is a rigid tube which softens upon hydration.

The stents prove to be very helpful in preventing the arteries from bursting, and in providing a supply of continuous blood flow to the weak arteries. The gel stent is constructed of soft collagen that is derived as gelatin. In the preparation of the gel stent soft collagen-derived gelatin is used. When gel stent is injected, it gets hydrated and swells, which creates an immobile channel that is soft and flexible, and which that adheres to ocular tissue. This operational procedure is minimally invasive. It significantly reduces the intraocular pressure (IOP) by the drainage of fluid to the subconjunctival passage, and the material minimizes the complications as compared to other synthetic materials.

The population of over 40 years of age, is more prone to the various eye diseases and the malfunctioning of various eye structures, thus the rise in the global geriatric population is one of the major factors with a promise to help boost the gel stent market. The rise in the incidence and prevalence of the condition of glaucoma, and minimally invasive procedures, as compared to the other kinds of surgeries, the increase in expenditure on healthcare, and the more technologically advanced procedures, are some of the factors that are expected to fuel the gel stent market growth.

The key driving factors of the global gel stent market are, the transforming healthcare systems such as hospitals/clinics, which are integrating the latest technology. The latest technological advancements in gel stent have given rise to a surge in the global demand. The continuous R&D activities in the medical science field, the ongoing technological advancements, and the developments taking place in different areas in developing economies offer lucrative growth opportunities.

The gel stent market is anticipated to expand at a significant rate across different geographical regions. The gel stent market players operating in this segment are working on their research and development process to build advanced products and increase their product portfolio. The prevalence of conditions like glaucoma, and other eye injuries, are on the rise across the North American countries due to a large growth in the population of the elderly. Furthermore, factors such as the surge in the cases of congenital glaucoma, on account of the shift in today’s lifestyles and habits, are expected to propel the growth of the market.

gel stent market Value Share Analysis, by Geography (2021)

The report titled “Gel Stent Market - Global Market Share, Trends, Analysis and Forecasts, 2022-2032” wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global gel stent market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.

The global gel stent market is segmented on the basis of Clinical Trials, End User, and geography. Based on Clinical Trials, the global gel stent market is segmented into Preclinical, Research, Clinical Phase I/II, Clinical Phase III, Clinical Phase I, Clinical Phase II. Based on End User, the global gel stent market is segmented into Eye Clinics, Eye Research Institutes, Hospitals. Based on geography, the global gel stent market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Belgium, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, Australia, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, the UAE, and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.

The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on gel stent market. Further, market share of prominent companies in the global gel stent market would also be estimated.

The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the Gel Stent companies. The global gel stent market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the Gel Stent business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global gel stent market.

Major players active in the global gel stent market include Clinical Phase Gel Stent, AqueSys, Allergan, and Preclinical Gel Stent.

The Gel Stent Market is segmented as follows:  

By Clinical Trials

• Preclinical
• Research
• Clinical Phase I/II
• Clinical Phase III
• Clinical Phase I
• Clinical Phase II

By End User

• Eye Clinics
• Eye Research Institutes
• Hospitals

 By Region

• North America 
• U.S. 
• Canada 
• Europe 
• Germany 
• UK 
• France 
• Spain 
• Italy 
• Rest of Europe 
• Asia Pacific 
• Japan 
• China 
• India 
• Australia 
• Rest of APAC 
• South America 
• Brazil 
• Rest of South America 
• Middle East & Africa 
• UAE 
• South Africa 
• Saudi Arabia 
• Rest of MEA